Asta Juzeniene

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Vaccines

Cancers

Journal of labelled compounds & radiopharmaceuticals

International journal of molecular sciences

The Norwegian Radium Hospital, Oslo University Hospital

University of Oslo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Norwegian Radium Hospital, Oslo University Hospital Jan 01 2012

Norway

Scientist (project group leader since 2015) :: Department of Radiation Biology

The Norwegian Radium Hospital, Oslo University Hospital Jan 01 2007 - Dec 31 2011

Norway

Post doc :: Department of Radiation Biology

Education History

University of Oslo Jan 15 2002 - Jan 12 2007

Norway

PHD

Publications

Mouldy Sioud, Asta Juzeniene, Stein Sæbøe-Larssen
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens. Vaccines 12 (6) (2024)
Mouldy Sioud, Asta Juzeniene, Stein Sæbøe-Larssen
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens. Vaccines 12 (6) (2024)
Mouldy Sioud, Asta Juzeniene, Stein Sæbøe-Larssen
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens. Vaccines 12 (6) (2024)
Vilde Yuli Stenberg, Anna Julie Kjøl Tornes, Hogne Røed Nilsen, Mona-Elisabeth R Revheim, Øyvind Sverre Bruland, Roy Hartvig Larsen, Asta Juzeniene
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212 Pb-NG001. Cancers 14 (11) (2022)
Ruth Gong Li, Kim Lindland, Sandra Karen Tonstad, Tina Bjørnlund Bønsdorff, Asta Juzeniene, Sara Westrøm, Roy Hartvig Larsen
Improved Formulation of 224Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP. Pharmaceutics 13 (5) (2021)
Asta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland, Roy Hartvig Larsen
Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancers 13 (4) (2021)
Vilde Yuli Stenberg, Roy Hartvig Larsen, Li-Wei Ma, Qian Peng, Petras Juzenas, Øyvind Sverre Bruland, Asta Juzeniene
Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer. International journal of molecular sciences 22 (9) (2021)
Leon Alexander Mclaren Berge, Bettina Kulle Andreassen, Jo Steinson Stenehjem, Trond Heir, Øystein Karlstad, Asta Juzeniene, Reza Ghiasvand, Inger Kristin Larsen, Adéle C Green, Marit Bragelien Veierød, Trude Eid Robsahm
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study. Clinical epidemiology 12 (2020)
Vilde Yuli Stenberg, Asta Juzeniene, Qingqi Chen, Xiaoming Yang, Øyvind Sverre Bruland, Roy Hartvig Larsen
Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer. Journal of labelled compounds & radiopharmaceuticals 63 (3) (2020)

Asta Juzeniene.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Asta Juzeniene